The massive investment, part of the company’s remarkable 90% growth since 2019, promises to produce billions of gummies annually while creating 225 new jobs.
“A lot of that growth is attributed to our gummies business,” said Jeff Boutelle, CEO at Pharmavite. “We make soft gels, we make tablets as well. And about four years ago, we ran out of capacity with our gummy manufacturing, so we started to evaluate how to expand our capacity.”
The facility’s location wasn’t chosen by chance. After evaluating 72 communities, New Albany emerged as the perfect match for Pharmavite’s vision of combining innovation with community impact. The Central Ohio region has gained a reputation as a hub for life sciences innovation in recent years, with Pharmavite noting its dedication to building a sustainable workforce through strong employee value propositions and active community engagement.
“We’ve been really successful getting talented, experienced individuals into our facility—great scientists, great manufacturing leaders,” said Kara Roeder, vice president of operations at Pharmavite.
“It’s great to see that there’s a lot of draw for particular skill sets, and we think that’s an advantage for us at Pharmavite. There’s people that see career opportunities here, and to be part of the life sciences core area is really great for us, and we think it’s going to enable us to have ongoing growth as a company.”
The 225,000-square-foot facility has one gummy manufacturing line, but as Boutelle pointed out, the 54-year-old company is just getting started:
“The facility is built such that we can add a second gummy line as the business evolves. This one gummy line will be producing three billion gummies per year, and again, if we add a second line, that’ll be six billion gummies per year coming out of this plant right here in Central Ohio.”
